Why IREN stock is jumping today: bitcoin miners rally, new 2x short ETF, Feb. 5 earnings

Why IREN stock is jumping today: bitcoin miners rally, new 2x short ETF, Feb. 5 earnings

New York, Jan 23, 2026, 12:51 PM EST — Regular session

  • IREN shares jumped roughly 11% during midday Nasdaq trading, beating the wider rally seen in bitcoin-related stocks.
  • This week saw the debut of a new -2x daily short ETF linked to IREN, offering traders a fresh quick-hit option to bet against the stock.
  • IREN scheduled its quarterly results release for Feb. 5, marking the next key date for both bulls and bears to watch.

Shares of IREN Limited surged roughly 11% on Friday, reaching a peak around $58.32 amid a strong rebound in bitcoin-linked stocks. At 12:51 p.m. EST, the price stood $5.82 higher at $58.08.

The bounce is key since IREN now acts as a high-beta stand-in for two crowded trades — crypto and AI infrastructure — both known for swift shifts. With earnings approaching, traders are focusing on the upcoming milestone instead of past headlines.

A new twist here is the expanding lineup of leveraged single-stock products linked to IREN, which can magnify short-term volatility. Tradr’s 2x short fund aims for twice the inverse of IREN’s daily price movement, resetting every day. Hold it longer, and the returns can stray from straightforward “-2x” calculations. (Tradr ETFs)

Bitcoin climbed roughly 1.6% on the day, boosting the mining sector. Marathon Digital jumped around 6.5%, Riot Platforms surged about 7.5%, and CleanSpark advanced close to 8.9%.

Tradr announced Thursday the launch of four new -200% inverse daily ETFs, including the Tradr 2X Short IREN Daily ETF (IREZ), now trading on Cboe. “We are excited to bring these inverse exposures to the market so that traders can efficiently express a … bearish view,” said Matt Markiewicz, Tradr’s head of product and capital markets. (PR Newswire)

IREN announced late Thursday that it plans to publish results for the quarter ending Dec. 31 on Feb. 5. The company will also hold a conference call at 5 p.m. Eastern. (GlobeNewswire)

The upcoming report could serve as a crucial turning point for the stock following January’s sharp swings. Investors want clarity on execution, cash requirements, and whether the company’s operational performance matches its trading narrative.

IREN, which operates bitcoin mining, has been shifting focus toward data centers and AI cloud infrastructure. Its profile took a sharp turn in November following news of a multi-year deal with Microsoft worth roughly $9.7 billion. The contract involves providing access to Nvidia chips, Reuters reported back then. (Reuters)

The risk is clear-cut. When bitcoin dips, miners usually drop along with it. Leveraged products then tend to amplify these moves, up or down. The Feb. 5 update is pivotal: a solid report could push prices higher, but any hint of slower growth or rising expenses might derail the rally fast.

Traders are zeroing in on two key indicators as the session winds down: bitcoin’s spot price movement and the strength of flows within the crypto-miner sector. All eyes will then shift to Feb. 5, when IREN releases its report and fields questions on the conference call.

Stock Market Today

  • Johnson & Johnson and Merck: Two Healthcare Stocks to Hold for 20 Years
    January 23, 2026, 1:21 PM EST. Johnson & Johnson (JNJ) and Merck (MRK) stand out as durable picks for long-term investors, driven by strong healthcare franchises. Merck's oncology focus, led by its blockbuster cancer drug Keytruda, positions it for continued sales growth despite looming patent expiration in 2028. The company also expands with new approvals and formulations to sustain momentum. Johnson & Johnson benefits from a diversified portfolio across pharmaceuticals and medical devices, consistently delivering revenue and earnings, even amid challenges. Both stocks offer attractive dividend yields - Merck at 3.1% with nearly doubling payouts historically, and Johnson & Johnson at 2.35%. Their scale, innovation, and dividend track records make them solid candidates for wealth accumulation over two decades, despite short-term volatility.
Moderna stock slides nearly 6% as CEO flags pullback in Phase III vaccine trials
Previous Story

Moderna stock slides nearly 6% as CEO flags pullback in Phase III vaccine trials

CoreWeave stock rises as insider sale filing lands and lawsuit deadline nears
Next Story

CoreWeave stock rises as insider sale filing lands and lawsuit deadline nears

Go toTop